ASHLEY PARSONS: Open Payments
NPI 1184248171 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 35 payments from 9 companies in 2025. Trend: 2023 $415 · 2024 $410 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $304 |
| Regeneron Healthcare Solutions, Inc. | 9 | $222 |
| GENZYME CORPORATION | 5 | $110 |
| GlaxoSmithKline, LLC. | 6 | $108 |
| Novartis Pharmaceuticals Corporation | 1 | $98 |
| CSL Behring | 3 | $90 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Optinose US, Inc. | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: DUPIXENT, BREZTRI, Rhapsido, TRELEGY ELLIPTA, TEZSPIRE, Haegarda, Andembry, NUCALA.
Industry payments across WV — which companies pay providers there.
